Skip to main content
All lobbying filings

PHILIPS HOLDING USA, INC.

Lobbying for PHILIPS HOLDING USA INC.

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $720,000.00 expenses · posted Jul 18, 2025

Official filing document

 Bills named in this filing 4
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • S 1399
    Health Tech Investment Act
  • S 1717
    Ensuring Patient Access to Critical Breakthrough Products Act of 2025
  • HR 1539
    Medical Device Electronic Labeling Act
 Lobbying activity 8
Chemicals/Chemical Industry

EPA ethylene oxide (EtO) regulations under FIFRA and NESHAP review - device sterilization

Tariff (miscellaneous tariff bills)

Tariff policy and the impact on patient access to medical devices Changes in U.S. Customs duties on imports, including negotiations on reciprocal tariffs with the EU and China.

Taxation/Internal Revenue Code

Changes in international tax provisions in H.R. 1, including section 899 and related BEAT provisions.

Medicare/Medicaid

Reimbursement of Algorithmic Health Based Services under Medicare and S. 1399, the Health Tech Investment Act (whole bill) Site neutrality payments under Medicare Medicare Physician Fee Schedule reform Extension of Medicare telehealth waivers - no specific legislation Medicare pathway to reimbursement for FDA-cleared Algorithm-Based Health Care Services/AI S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act - whole bill H.R. 1 - the One Big Beautiful Bill Act - Section 71202, Temporary payment increase under the Medicare physician fee schedule to account for exceptional circumstances

Health Issues

Third-party servicing of medical devices, right-to-repair of medical devices, remanufacturing of medical devices Cybersecurity of medical devices FDA regulation of Artificial Intelligence EPA ethylene oxide (EtO) regulations under FIFRA and NESHAP review - device sterilization Efforts to improve access to healthcare for underserved communities and activities to enhance maternal healthcare Sustainability in healthcare throughout the value chain including procurement, product development and design, and the benefits thereof H.R. 1539, the Medical Device Electronic Labeling Act

Budget/Appropriations

FY 2025 Veterans Affairs Appropriations, in general with some focus on telehealth provisions FY 2025 Defense Department Appropriations National Defense Authorization Act for Fiscal Year 2025, including issues related to RATE and low helium MRIs

Veterans

U.S. Department of Veteran Affairs' acquisition process Telehealth for veterans Tele-critical care for Dept of Defense Nationwide expansion of tele-critical care program Digital Pathology RATE (Rapid Analysis of Threat Exposure)

Defense

Telehealth in DOD Issues related to COVID-19 pandemic response and other infectious diseases

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem